Loading
Life sciences · Interventional Study
ClinicalTrials.gov · November 3, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07799480). This is a study registration, not published results. Lead sponsor: University of North Carolina, Chapel Hill. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 60 participants (ESTIMATED). Conditions: Antenatal Depression. Interventions: OTHER: Sham (placebo) tACS; OTHER: IAF-tACS; OTHER: PandA-tACS. Primary outcome measures: Safety via the presence of any serious AEs , Day 1 to within 90 days of expected delivery date.; Tolerability of PandA-tACS , Immediately after intervention; Feasibility of PandA-tACS , Through completion of the study, roughly 2 years; Change in aperiodic slope in the dlPFC region. , Immediately before and after 40 minutes of stimulation (on single interventional session day).. Brief summary: The purpose of this pilot trial is to primarily assess safety, feasibility, and tolerability of PandA-tACS in antenatal depression and determine whether a single PandA-tACS session produces greater left dlPFC aperiodic slope flattening (reduction) from pre- to post-stimulation than IAF-tACS and sham.